AbbVie, Nxera ink licensing deal worth up to $1.5B for bowel disease therapy
This is a summary aggregated from Seeking Alpha. Read the complete article on the original site:
Read full article at Seeking Alpha
More Health & Medical News
Apple Will Check Public iCloud Links for Harmful Content Starting in iOS 27.3
MacRumors · 40 min ago
Hearts lose Miller for two months as injuries mount
BBC Sport Football · 52 min ago
Campbell has full lower body movement after neck injury
BBC Sport · 1 hr ago
CVS to split off drugstore business in major breakup of healthcare giant; shares fall 10%
CNBC · 1 hr ago
British healthcare worker with Ebola evacuated from DR Congo to UK
The Guardian · 1 hr ago
My therapist thinks I should chuck the Amazon Bee Frontier out a window
The Verge · 1 hr ago